Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This small but inventive island is putting transgenics and nanotechnology to novel uses. A pay rise might be all it needs to lure its expatriate scientists home, says Paul Smaglik.
Michigan, Minnesota and Wisconsin have had mixed fortunes in their efforts to build up their research infrastructure. Partnerships may prove to be the strongest construction, says Paul Smaglik.
The Pacific Northwest of North America doesn't just mean Microsoft, Intel and some big trees. Already noted for the quality of its biological research, the biotechnology base in cities such as Vancouver is set to grow too, as Virginia Gewin finds out.
Public funding problems have prevented Italy from catching up with other European scientific hubs. But some privately funded local initiatives show glimmers of hope. Quirin Schiermeier and Alison Abbott report.
Biologists in Osaka think that their city's 'un-Japanese' culture makes it the ideal part of the country to become a hub for biotechnology. David Cyranoski investigates.
Despite funding uncertainties, Berlin's facilities, charisma and cosmopolitan atmosphere continue to draw researchers from across Europe, says Quirin Schiermeier.
Switzerland is proving that small countries can make a big impression in science. It is recruiting some of the brightest young researchers from all over the world and convincing them to stay, says Quirin Schiermeier.
